NSIM
ABBV icon

North Star Investment Management’s AbbVie ABBV Stock Holding History

North Star Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.4M Sell
75,363
-1,089
-1% -$242K 0.99% 14
2025
Q4 		$17.5M Sell
76,452
-476
-0.6% -$108K 1.1% 14
2025
Q3 		$17.8M Buy
76,928
+18
+0% +$3.67K 1.14% 14
2025
Q2 		$14.3M Sell
76,910
-473
-0.6% -$87.9K 1% 16
2025
Q1 		$16.2M Sell
77,383
-7,922
-9% -$1.54M 1.18% 12
2024
Q4 		$15.2M Sell
85,305
-126
-0.1% -$23.2K 1.06% 14
2024
Q3 		$16.9M Sell
85,431
-651
-0.8% -$121K 1.17% 14
2024
Q2 		$14.8M Sell
86,082
-3,608
-4% -$598K 1.08% 14
2024
Q1 		$16.3M Buy
89,690
+2,763
+3% +$476K 1.17% 13
2023
Q4 		$13.5M Sell
86,927
-85
-0.1% -$12.4K 1.04% 15
2023
Q3 		$13M Sell
87,012
-477
-0.5% -$70K 1.09% 12
2023
Q2 		$11.8M Sell
87,489
-453
-0.5% -$66.4K 0.96% 17
2023
Q1 		$14M Buy
87,942
+2,895
+3% +$443K 1.16% 11
2022
Q4 		$13.7M Sell
85,047
-5,505
-6% -$844K 1.22% 12
2022
Q3 		$12.2M Buy
90,552
+29
+0% +$4.16K 1.19% 15
2022
Q2 		$13.9M Sell
90,523
-1,206
-1% -$184K 1.26% 14
2022
Q1 		$14.9M Sell
91,729
-5,479
-6% -$796K 1.16% 15
2021
Q4 		$13.2M Sell
97,208
-37
-0% -$4.37K 0.92% 19
2021
Q3 		$10.5M Buy
97,245
+4,118
+4% +$471K 0.85% 25
2021
Q2 		$10.5M Buy
93,127
+1,266
+1% +$143K 0.83% 27
2021
Q1 		$9.94M Buy
91,861
+603
+0.7% +$64.5K 0.94% 21
2020
Q4 		$9.78M Sell
91,258
-2,497
-3% -$240K 1.02% 17
2020
Q3 		$8.21M Buy
93,755
+7,409
+9% +$698K 0.97% 21
2020
Q2 		$8.48M Sell
86,346
-11,161
-11% -$983K 1.11% 15
2020
Q1 		$7.43M Buy
97,507
+7,471
+8% +$636K 1.1% 15
2019
Q4 		$7.97M Buy
90,036
+31
+0% +$2.57K 0.83% 21
2019
Q3 		$6.82M Buy
90,005
+29,672
+49% +$2.03M 0.76% 28
2019
Q2 		$4.39M Sell
60,333
-1,488
-2% -$117K 0.51% 47
2019
Q1 		$4.98M Buy
61,821
+611
+1% +$50K 0.58% 38
2018
Q4 		$5.64M Buy
61,210
+338
+0.6% +$29.7K 0.74% 28
2018
Q3 		$5.76M Buy
60,872
+914
+2% +$86.7K 0.64% 36
2018
Q2 		$5.55M Sell
59,958
-210
-0.3% -$20.5K 0.64% 32
2018
Q1 		$5.7M Sell
60,168
-1,898
-3% -$208K 0.68% 31
2017
Q4 		$6M Sell
62,066
-135
-0.2% -$12.7K 0.73% 27
2017
Q3 		$5.53M Buy
62,201
+88
+0.1% +$6.7K 0.7% 31
2017
Q2 		$4.5M Buy
62,113
+2,628
+4% +$177K 0.6% 36
2017
Q1 		$3.88M Buy
59,485
+450
+0.8% +$28.3K 0.53% 45
2016
Q4 		$3.7M Buy
59,035
+6,107
+12% +$373K 0.56% 39
2016
Q3 		$3.34M Buy
52,928
+506
+1% +$32.8K 0.59% 41
2016
Q2 		$3.25M Sell
52,422
-594
-1% -$36.2K 0.6% 38
2016
Q1 		$3.03M Sell
53,016
-92
-0.2% -$5.13K 0.58% 43
2015
Q4 		$3.15M Buy
53,108
+19,808
+59% +$1.14M 0.61% 39
2015
Q3 		$1.81M Sell
33,300
-642
-2% -$41.8K 0.37% 77
2015
Q2 		$2.28M Sell
33,942
-1,551
-4% -$101K 0.42% 70
2015
Q1 		$2.08M Buy
35,493
+36
+0.1% +$2.17K 0.39% 73
2014
Q4 		$2.32M Buy
35,457
+6,451
+22% +$407K 0.44% 66
2014
Q3 		$1.68M Buy
29,006
+3,085
+12% +$171K 0.34% 90
2014
Q2 		$1.46M Buy
25,921
+1,105
+4% +$58K 0.29% 105
2014
Q1 		$1.28M Buy
24,816
+245
+1% +$12.4K 0.27% 115
2013
Q4 		$1.3M Sell
24,571
-6,897
-22% -$339K 0.28% 105
2013
Q3 		$1.41M Sell
31,468
-7,250
-19% -$321K 0.38% 71
2013
Q2 		$1.6M Buy
+38,718
New +$1.69M 0.41% 64

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

North Star Investment Management's ABBV Position: Q1 2026 in Review

North Star Investment Management reduced its AbbVie (ABBV) stake by 1.4% in Q1 2026, selling an estimated $242K and leaving 75,363 shares worth $16.4M. The position accounts for 0.99% of the portfolio, ranked #14.

North Star Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.8M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • North Star Investment Management held 75,363 shares of AbbVie worth $16.4M as of Q1 2026.
  • North Star Investment Management sold 1,089 AbbVie shares in Q1 2026, an estimated $242K.
  • AbbVie made up 0.99% of North Star Investment Management's portfolio in Q1 2026, its #14 holding.
  • North Star Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • North Star Investment Management's AbbVie position peaked at $17.8M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.